IBS – an undertreated condition

With a prevalence of 11 per cent, IBS is considered one of the world’s most common conditions. Although innocuous, it significantly impacts the sufferer’s quality of life and leads to high societal costs. Today, there is no effective pharmacological treatment for IBS, but research is still ongoing to solve the riddle and achieve a breakthrough. BioStock takes a closer look at the condition.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/11/ibs-an-undertreated-condition/

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/en/